UniProt ID | INSR_MOUSE | |
---|---|---|
UniProt AC | P15208 | |
Protein Name | Insulin receptor | |
Gene Name | Insr | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1372 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein. |
|
Protein Description | Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). When present in a hybrid receptor with IGF1R, binds IGF1 (By similarity).. | |
Protein Sequence | MGFGRGCETTAVPLLVAVAALLVGTAGHLYPGEVCPGMDIRNNLTRLHELENCSVIEGHLQILLMFKTRPEDFRDLSFPKLIMITDYLLLFRVYGLESLKDLFPNLTVIRGSRLFFNYALVIFEMVHLKELGLYNLMNITRGSVRIEKNNELCYLATIDWSRILDSVEDNYIVLNKDDNEECGDVCPGTAKGKTNCPATVINGQFVERCWTHSHCQKVCPTICKSHGCTAEGLCCHKECLGNCSEPDDPTKCVACRNFYLDGQCVETCPPPYYHFQDWRCVNFSFCQDLHFKCRNSRKPGCHQYVIHNNKCIPECPSGYTMNSSNLMCTPCLGPCPKVCQILEGEKTIDSVTSAQELRGCTVINGSLIINIRGGNNLAAELEANLGLIEEISGFLKIRRSYALVSLSFFRKLHLIRGETLEIGNYSFYALDNQNLRQLWDWSKHNLTITQGKLFFHYNPKLCLSEIHKMEEVSGTKGRQERNDIALKTNGDQASCENELLKFSFIRTSFDKILLRWEPYWPPDFRDLLGFMLFYKEAPYQNVTEFDGQDACGSNSWTVVDIDPPQRSNDPKSQTPSHPGWLMRGLKPWTQYAIFVKTLVTFSDERRTYGAKSDIIYVQTDATNPSVPLDPISVSNSSSQIILKWKPPSDPNGNITHYLVYWERQAEDSELFELDYCLKGLKLPSRTWSPPFESDDSQKHNQSEYDDSASECCSCPKTDSQILKELEESSFRKTFEDYLHNVVFVPRPSRKRRSLEEVGNVTATTLTLPDFPNVSSTIVPTSQEEHRPFEKVVNKESLVISGLRHFTGYRIELQACNQDSPDERCSVAAYVSARTMPEAKADDIVGPVTHEIFENNVVHLMWQEPKEPNGLIVLYEVSYRRYGDEELHLCVSRKHFALERGCRLRGLSPGNYSVRVRATSLAGNGSWTEPTYFYVTDYLDVPSNIAKIIIGPLIFVFLFSVVIGSIYLFLRKRQPDGPMGPLYASSNPEYLSASDVFPSSVYVPDEWEVPREKITLLRELGQGSFGMVYEGNAKDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSHLRSLRPDAENNPGRPPPTLQEMIQMTAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTASSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDPPDNCPERLTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSFFYSEENKAPESEELEMEFEDMENVPLDRSSHCQREEAGGREGGSSLSIKRTYDEHIPYTHMNGGKKNGRVLTLPRSNPS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
43 | N-linked_Glycosylation | PGMDIRNNLTRLHEL CCCCCCCCHHHHHHH | 32.70 | - | |
52 | N-linked_Glycosylation | TRLHELENCSVIEGH HHHHHHCCCEEEECE | 35.67 | - | |
105 | N-linked_Glycosylation | SLKDLFPNLTVIRGS HHHHHCCCCEEEECC | 40.80 | - | |
138 | N-linked_Glycosylation | LGLYNLMNITRGSVR CCHHHHHCCCCCCEE | 35.33 | - | |
242 | N-linked_Glycosylation | CHKECLGNCSEPDDP ECHHHHCCCCCCCCC | 17.13 | - | |
282 | N-linked_Glycosylation | FQDWRCVNFSFCQDL CCCEEEEEEHHHCCC | 30.39 | - | |
284 | Phosphorylation | DWRCVNFSFCQDLHF CEEEEEEHHHCCCCH | 21.65 | 28418008 | |
322 | N-linked_Glycosylation | CPSGYTMNSSNLMCT CCCCCEECCCCCEEC | 34.19 | - | |
364 | N-linked_Glycosylation | LRGCTVINGSLIINI HCCCEEECCEEEEEE | 29.66 | - | |
400 | Phosphorylation | GFLKIRRSYALVSLS HHHHHHHHHHHHHHH | 12.62 | - | |
401 | Phosphorylation | FLKIRRSYALVSLSF HHHHHHHHHHHHHHH | 11.35 | - | |
407 | Phosphorylation | SYALVSLSFFRKLHL HHHHHHHHHHHHHCC | 18.16 | - | |
419 | Phosphorylation | LHLIRGETLEIGNYS HCCCCCCEEEECCEE | 32.30 | 24719451 | |
424 | N-linked_Glycosylation | GETLEIGNYSFYALD CCEEEECCEEEEEEC | 34.63 | - | |
426 | Phosphorylation | TLEIGNYSFYALDNQ EEEECCEEEEEECCC | 18.77 | 24719451 | |
445 | N-linked_Glycosylation | LWDWSKHNLTITQGK HHHHHHCCEEEECCE | 42.49 | 19656770 | |
447 | Phosphorylation | DWSKHNLTITQGKLF HHHHCCEEEECCEEE | 27.56 | - | |
457 | Phosphorylation | QGKLFFHYNPKLCLS CCEEEEECCHHHHHH | 28.18 | - | |
541 | N-linked_Glycosylation | YKEAPYQNVTEFDGQ CCCCCCCCCEEECCC | 36.51 | - | |
635 | N-linked_Glycosylation | LDPISVSNSSSQIIL CCCEECCCCCCEEEE | 43.70 | - | |
653 | N-linked_Glycosylation | PPSDPNGNITHYLVY CCCCCCCCEEEEEEE | 42.50 | - | |
700 | N-linked_Glycosylation | SDDSQKHNQSEYDDS CCCHHCCCHHHCCCC | 54.85 | - | |
717 | Phosphorylation | ECCSCPKTDSQILKE HHCCCCCCHHHHHHH | 26.48 | 28059163 | |
759 | N-linked_Glycosylation | RSLEEVGNVTATTLT CCHHHHCCEEEEEEE | 32.89 | - | |
772 | N-linked_Glycosylation | LTLPDFPNVSSTIVP EECCCCCCCCCCCCC | 46.42 | - | |
910 | N-linked_Glycosylation | LRGLSPGNYSVRVRA CCCCCCCCEEEEEEE | 29.32 | - | |
923 | N-linked_Glycosylation | RATSLAGNGSWTEPT EEEECCCCCCCCCCE | 35.40 | - | |
989 | Phosphorylation | YASSNPEYLSASDVF CCCCCCCCCCHHHCC | 13.76 | 22817900 | |
1001 | Phosphorylation | DVFPSSVYVPDEWEV HCCCCCCCCCCCCCC | 14.28 | 20332342 | |
1012 | Ubiquitination | EWEVPREKITLLREL CCCCCHHHHHHHHHH | 42.12 | 22790023 | |
1012 | Ubiquitination | EWEVPREKITLLREL CCCCCHHHHHHHHHH | 42.12 | 22790023 | |
1037 | Ubiquitination | GNAKDIIKGEAETRV CCHHHHHCCCCEEEE | 51.54 | 22790023 | |
1037 | Ubiquitination | GNAKDIIKGEAETRV CCHHHHHCCCCEEEE | 51.54 | 22790023 | |
1047 | Ubiquitination | AETRVAVKTVNESAS CEEEEEEEECCCCCC | 36.70 | 22790023 | |
1047 | Ubiquitination | AETRVAVKTVNESAS CEEEEEEEECCCCCC | 36.70 | 22790023 | |
1052 | Phosphorylation | AVKTVNESASLRERI EEEECCCCCCHHHHH | 20.25 | - | |
1054 | Phosphorylation | KTVNESASLRERIEF EECCCCCCHHHHHHH | 36.92 | - | |
1122 | Phosphorylation | NPGRPPPTLQEMIQM CCCCCCCCHHHHHHH | 47.01 | 28059163 | |
1171 | Phosphorylation | KIGDFGMTRDIYETD EECCCCCCCCEEECC | 26.10 | 23375375 | |
1175 | Phosphorylation | FGMTRDIYETDYYRK CCCCCCEEECCCCCC | 19.64 | 8940173 | |
1177 | Phosphorylation | MTRDIYETDYYRKGG CCCCEEECCCCCCCC | 16.60 | 22499769 | |
1179 | Phosphorylation | RDIYETDYYRKGGKG CCEEECCCCCCCCCC | 16.76 | 25521595 | |
1180 | Phosphorylation | DIYETDYYRKGGKGL CEEECCCCCCCCCCC | 14.52 | 25521595 | |
1185 | Ubiquitination | DYYRKGGKGLLPVRW CCCCCCCCCCCCEEE | 55.86 | 22790023 | |
1185 | Ubiquitination | DYYRKGGKGLLPVRW CCCCCCCCCCCCEEE | 55.86 | 22790023 | |
1337 | Phosphorylation | AGGREGGSSLSIKRT CCCCCCCCCCEEEEE | 38.67 | 23737553 | |
1338 | Phosphorylation | GGREGGSSLSIKRTY CCCCCCCCCEEEEEC | 29.43 | 27180971 | |
1340 | Phosphorylation | REGGSSLSIKRTYDE CCCCCCCEEEEECCC | 28.19 | 25521595 | |
1344 | Phosphorylation | SSLSIKRTYDEHIPY CCCEEEEECCCCCCC | 30.26 | 22817900 | |
1345 | Phosphorylation | SLSIKRTYDEHIPYT CCEEEEECCCCCCCC | 24.30 | 22817900 | |
1351 | Phosphorylation | TYDEHIPYTHMNGGK ECCCCCCCCCCCCCC | 14.52 | 22817900 | |
1352 | Phosphorylation | YDEHIPYTHMNGGKK CCCCCCCCCCCCCCC | 14.86 | 23684622 | |
1365 | Phosphorylation | KKNGRVLTLPRSNPS CCCCEEEECCCCCCC | 31.68 | 21454597 | |
1369 | Phosphorylation | RVLTLPRSNPS---- EEEECCCCCCC---- | 51.67 | 29514104 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of INSR_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of INSR_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SRBS1_MOUSE | Sorbs1 | physical | 9447983 | |
SH2B2_MOUSE | Sh2b2 | physical | 10196204 | |
FLOT1_MOUSE | Flot1 | physical | 16455755 | |
CAV3_MOUSE | Cav3 | physical | 16455755 | |
GRB10_MOUSE | Grb10 | physical | 9062339 | |
PLAK_MOUSE | Jup | physical | 24567360 | |
AKT1_MOUSE | Akt1 | physical | 19122674 | |
SRC_MOUSE | Src | physical | 19122674 | |
ARRB2_MOUSE | Arrb2 | physical | 19122674 | |
CLK1_HUMAN | CLK1 | physical | 26496610 | |
PDIA3_HUMAN | PDIA3 | physical | 26496610 | |
IGF1R_HUMAN | IGF1R | physical | 26496610 | |
FAF2_HUMAN | FAF2 | physical | 26496610 | |
NSF1C_HUMAN | NSFL1C | physical | 26496610 | |
UBE2O_HUMAN | UBE2O | physical | 26496610 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-445, AND MASSSPECTROMETRY. | |
"The mouse C2C12 myoblast cell surface N-linked glycoproteome:identification, glycosite occupancy, and membrane orientation."; Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I.,Bausch-Fluck D., Elliott S.T., Boheler K.R., Van Eyk J.E.,Wollscheid B.; Mol. Cell. Proteomics 8:2555-2569(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-445, AND MASSSPECTROMETRY. |